Study: Anti-Delta-Like 4 Ligand and Irinotecan Reduced Colon Cancer Stem Cells in Mutant KRAS Tumors
A combination of anti-delta-like 4 ligand and irinotecan significantly reduced colon cancer stem cells and increased tumor cell apoptosis in mutant KRAS tumors, according to a study published in Cancer Research.
